Benitec Biopharma Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Benitec Biopharma Limited with three other
companies in this sector in Australia:
sales of 3.24 million Australian Dollars [US$2.45 million]
of which 64%
Starpharma Holdings Limited
(4.63 million Australian Dollars [US$3.50 million]
of which 100%
was Dendritic), and
(3.39 million Australian Dollars [US$2.56 million]
Benitec Biopharma Limited reported sales of A$4.05 million (US$3.07 million)
June of 2016.
increase of 19.3%
versus 2015, when the company's sales were A$3.40 million.
Sales at Benitec Biopharma Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 2,487%).